Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome

Wang, J. Y.; Yeh, T. F.; Lin, Y. C.; Miyamura, K.; Holmskov, U.; Reid, K. B.
September 1996
Thorax;Sep1996, Vol. 51 Issue 9, p907
Academic Journal
No abstract available.


Related Articles

  • Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant. Müller, Hanna; End, Caroline; Renner, Marcus; Helmke, Burkhard M.; Gassler, Nikolaus; Weiss, Christel; Hartl, Dominik; Griese, Matthias; Hafner, Mathias; Poustka, Annemarie; Mollenhauer, Jan; Poeschl, Johannes // Respiratory Research;2007, Vol. 8, p69 

    Background: Deleted in Malignant Brain Tumors 1 (DMBT1) is a secreted scavenger receptor cysteine-rich protein that binds various bacteria and is thought to participate in innate pulmonary host defense. We hypothesized that pulmonary DMBT1 could contribute to respiratory distress syndrome in...

  • The Pulmonary Surfactant System: Biochemical and Clinical Aspects. Creuwels, L.A.J.M.; van Golde, L.M.G.; Haagsman, H.P. // Lung;1997, Vol. 175 Issue 1, p1 

    This article starts with a brief account of the history of research on pulmonary surfactant. We will then discuss the morphological aspects and composition of the pulmonary surfactant system. We describe the hydrophilic surfactant proteins A and D and the hydrophobic surfactant proteins B and...

  • Uso de surfactante pulmonar exógeno en el neonato pretérmino con Síndrome de Dificultad Respiratoria, Estrategia de Rescate. Experiencia del Instituto Nacional de Perinatología 1997-1998. Salinas Ramiírez, Vicente; Angel Gúzman Reyes, Lidio; Mórales Suárez, Moises; Hernández Pelaez, Graciela; Yllescas Medrano, Eucario; Albert Zapata Pallagi, James // Perinatologia y Reproduccion Humana;oct-dic1999, Vol. 13 Issue 4, p286 

    KEY WORDS: [Surfactant pulmonary exogenous, preterm infants, neonatal respiratory distress syndrome, hyaline membrane disease.]

  • Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Amizuka, Takasuke; Shimizu, Hiroshi; Niida, Yuichi; Ogawa, Yunosuke // European Journal of Pediatrics;2003, Vol. 162 Issue 10, p697 

    Unlabelled: We studied the clinical and biochemical factors associated with surfactant dysfunction and factors affecting the responsiveness to exogenous surfactant among 27 neonates with haemorrhagic pulmonary oedema (HPE). HPE was defined as the presence of a large amount of...

  • The use of artificial pulmonary surfactant in neonatal respiratory distress. Yong-Sung Choi // Journal of the Korean Medical Association / Taehan Uisa Hyophoe ;Apr2015, Vol. 58 Issue 4, p330 

    Pulmonary surfactant instillation is the treatment of choice in neonatal respiratory distress syndrome. The development of artificial surfactant has three decades of history. Animal-derived artificial surfactant is used in most countries and consists of 80% phospholipids and glycerol. 10% of the...

  • Changes in Pulmonary Mechanics After the Administration of Surfactant to Infants With Respiratory Distress Syndrome.  // JAMA: Journal of the American Medical Association;2/3/89, Vol. 261 Issue 5, p763 

    Assesses pulmonary mechanics in 35 premature infants with respiratory distress syndrome. Administration of surfactant; Measurement of transpulmonary pressure; Mechanical changes apparent during spontaneous respiration and which can be masked if measurements are made during mechanical ventilation.

  • Secondary Surfactant Deficiency in Neonates. Bissinger, Robin; Carlson, Cheryl; Hulsey, Tom; Eicher, Dorothea // Journal of Perinatology;Oct2004, Vol. 24 Issue 10, p663 

    Surfactant treatment has become the standard of care in premature infants with respiratory distress syndrome (RDS). Pulmonary hemorrhage, pulmonary edema, pneumonia, and atelectasis have been shown to liberate inflammatory mediators and plasma proteins, which damage type II pneumocytes and...

  • Synthetic Pulmonary Surfactant Preparations: New Developments and Future Trends. Mingarro, Ismael; Lukovic, Dunja; Vilar, Marçal; Pérez-Gil, Jesús // Current Medicinal Chemistry;2008, Vol. 15 Issue 4, p393 

    Pulmonary surfactant is a lipid-protein complex that coats the interior of the alveoli and enables the lungs to function properly. Upon its synthesis, lung surfactant adsorbs at the interface between the air and the hypophase, a capillary aqueous layer covering the alveoli. By lowering and...

  • Surfactants: past, present and future. Halliday, H. L. // Journal of Perinatology;May2008 Supplement, Vol. 28, pS47 

    In 1929 Kurt von Neergaard performed experiments suggesting the presence of pulmonary surfactant and its relevance to the newborn's first breath. Almost 25 years later, Richard Pattle, John Clements and Chris Macklin, each working on the effects of nerve gases on the lungs, contributed to the...

  • Respiratory Distress in the Newborn. Hermansen, Christian L.; Lorah, Kevin N. // American Family Physician;10/1/2007, Vol. 76 Issue 7, p987 

    The most common etiology of neonatal respiratory distress is transient tachypnea of the newborn; this is triggered by excessive lung fluid, and symptoms usually resolve spontaneously. Respiratory distress syndrome can occur in premature infants as a result of surfactant deficiency and...


Read the Article


Sign out of this library

Other Topics